Kodiak Sciences, Inc. (KOD)
37.73
-1.39
(-3.56%)
USD |
NASDAQ |
Aug 28, 16:00
37.73
0.00 (0.00%)
After-Hours: 16:51
Kodiak Sciences Total Assets (Quarterly) : 256.81M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 256.81M |
| March 31, 2026 | 306.01M |
| December 31, 2025 | 351.53M |
| September 30, 2025 | 218.07M |
| June 30, 2025 | 256.72M |
| March 31, 2025 | 297.91M |
| December 31, 2024 | 335.58M |
| September 30, 2024 | 372.67M |
| June 30, 2024 | 401.58M |
| March 31, 2024 | 434.76M |
| December 31, 2023 | 479.37M |
| September 30, 2023 | 547.65M |
| June 30, 2023 | 589.66M |
| March 31, 2023 | 640.33M |
| December 31, 2022 | 666.63M |
| September 30, 2022 | 723.99M |
| June 30, 2022 | 781.90M |
| March 31, 2022 | 850.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 904.22M |
| September 30, 2021 | 958.21M |
| June 30, 2021 | 997.60M |
| March 31, 2021 | 1.033B |
| December 31, 2020 | 1.067B |
| September 30, 2020 | 480.74M |
| June 30, 2020 | 429.37M |
| March 31, 2020 | 443.04M |
| December 31, 2019 | 358.87M |
| September 30, 2019 | 68.92M |
| June 30, 2019 | 78.28M |
| March 31, 2019 | 87.08M |
| December 31, 2018 | 92.19M |
| September 30, 2018 | 17.12M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 3.244M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 195.72M |
| Shareholders Equity (Quarterly) | 61.10M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 2.489 |
| Net Debt Paydown Yield | 0.12% |